Phathom Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
23.83
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.32
|
-1.32
|
0.00
|
0.00%
|
|
2022-06-30
|
-1.03
|
-1.33
|
-0.30
|
-29.13%
|
|
2022-03-31
|
-0.97
|
-1.07
|
-0.10
|
-10.31%
|
|
2021-12-31
|
-1.03
|
-0.95
|
0.08
|
7.77%
|
|
2021-09-30
|
-0.98
|
-0.98
|
0.00
|
0.00%
|
|
2021-06-30
|
-1.07
|
-1.00
|
0.07
|
6.54%
|
|
2021-03-31
|
-1.19
|
-0.96
|
0.23
|
19.33%
|
|
2020-12-31
|
-1.01
|
-1.58
|
-0.57
|
-56.44%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.72
|
|
2021-12-31
|
-3.89
|
|
2020-12-31
|
-3.86
|
|
2019-12-31
|
-13.27
|